Department of Radiology

Publications

2016

Pandit-Taskar N, O'Donoghue JA, Ruan S, Lyashchenko SK, Carrasquillo JA, Heller G, et al. First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake. J Nucl Med. 2016;57(12):1858-1864.

2015

Pandit-Taskar N, O'Donoghue JA, Durack JC, Lyashchenko SK, Cheal SM, Beylergil V, et al. A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer. Clin Cancer Res. 2015;21(23):5277-85.

Zhao N, Pei S-, Qi J, Zeng Z, Iyer SP, Lin P, et al. Oligonucleotide aptamer-drug conjugates for targeted therapy of acute myeloid leukemia. Biomaterials. 2015;67:42-51.

Eskreis-Winkler S, Deh K, Gupta A, Liu T, Wisnieff C, Jin M, et al. Multiple sclerosis lesion geometry in quantitative susceptibility mapping (QSM) and phase imaging. J Magn Reson Imaging. 2015;42(1):224-9.

Bellat V, Chassagnon R, Heintz O, Saviot L, Vandroux D, Millot N. A multi-step mechanism and integrity of titanate nanoribbons. Dalton Trans. 2015;44(3):1150-60.

Papa A-, Boudon J, Bellat V, Loiseau A, Bisht H, Sallem F, et al. Dispersion of titanate nanotubes for nanomedicine: comparison of PEI and PEG nanohybrids. Dalton Trans. 2015;44(2):739-46.

Yang Y, Zhang X, Cui M, Zhang J, Guo Z, Li Y, et al. Preliminary Characterization and In Vivo Studies of Structurally Identical (18)F- and (125)I-Labeled Benzyloxybenzenes for PET/SPECT Imaging of β-Amyloid Plaques. Sci Rep. 2015;5:12084.

Leelawattanachai J, Kwon K-, Michael P, Ting R, Kim J-, Jin MM. Side-by-Side Comparison of Commonly Used Biomolecules That Differ in Size and Affinity on Tumor Uptake and Internalization. PLoS One. 2015;10(4):e0124440.

Jeitner TM, Kalogiannis M, Patrick PA, Gomolin I, Palaia T, Ragolia L, et al. Inflaming the diseased brain: a role for tainted melanins. Biochim Biophys Acta. 2015;1852(5):937-50.

Ahmed M, Cheng M, Zhao Q, Goldgur Y, Cheal SM, Guo H-, et al. Humanized Affinity-matured Monoclonal Antibody 8H9 Has Potent Antitumor Activity and Binds to FG Loop of Tumor Antigen B7-H3. J Biol Chem. 2015;290(50):30018-29.